Ipamorelin vs Hexarelin
A comprehensive, data-driven comparison of Ipamorelin (NNC 26-0161) and Hexarelin (Examorelin). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Ipamorelin NNC 26-0161 | Hexarelin Examorelin |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Not submitted |
| Category | Growth Hormone | Growth Hormone |
| Primary Use | Growth hormone optimization | Growth hormone optimization and cardiac protection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 200-300mcg 2-3x daily | 100-200mcg 2x daily (pulsed use recommended) |
| Frequency | Daily | Daily |
| Mechanism | Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH release without affecting cortisol or prolactin | Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Ipamorelin is generally more affordable ($35 - $70/mo) compared to Hexarelin ($40 - $80/mo).
Which Is Better For...
Ipamorelin
More budget-friendly option with lower monthly costs
Ipamorelin
Fewer commonly reported side effects
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Ipamorelin | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
| Hexarelin | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Ipamorelin works via Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH. Hexarelin works via Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation. They differ in FDA approval status, efficacy data, and cost.
Ipamorelin typically costs $35 - $70/mo, while Hexarelin costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Ipamorelin is not FDA-approved (Category 2 (pending reclassification)). Hexarelin is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Ipamorelin include Injection site reactions, Increased hunger, Headache. Common side effects of Hexarelin include Increased appetite, Cortisol elevation, Prolactin elevation. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Ipamorelin is a pentapeptide that selectively stimulates growth hormone release by mimicking ghrelin, the hunger hormone. Unlike many other GH secretagogues, ipamorelin does not significantly increase...
View Full Ipamorelin GuideHexarelin is a synthetic hexapeptide GH secretagogue that is significantly more potent than GHRP-6. Beyond stimulating growth hormone release, research has revealed unique cardioprotective effects ind...
View Full Hexarelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Ipamorelin and Hexarelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.